Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9176 |
High Similarity |
NPD7472 |
Approved |
0.9123 |
High Similarity |
NPD6797 |
Phase 2 |
0.9118 |
High Similarity |
NPD7054 |
Approved |
0.907 |
High Similarity |
NPD7251 |
Discontinued |
0.9064 |
High Similarity |
NPD7074 |
Phase 3 |
0.9017 |
High Similarity |
NPD7808 |
Phase 3 |
0.8947 |
High Similarity |
NPD3818 |
Discontinued |
0.8895 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.883 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.883 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.883 |
High Similarity |
NPD6166 |
Phase 2 |
0.881 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.88 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8793 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD8313 |
Approved |
0.875 |
High Similarity |
NPD8312 |
Approved |
0.8631 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8529 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8452 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8439 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8363 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8324 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8304 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8304 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8276 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8216 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8207 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8192 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8144 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8107 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8101 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8079 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8057 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8056 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8046 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7989 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7977 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7941 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7886 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7886 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7877 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7841 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7826 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7824 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7824 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7824 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7824 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7824 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7824 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7824 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7821 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7809 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7802 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7795 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7795 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7795 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7789 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7789 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7755 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7755 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7754 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7727 |
Intermediate Similarity |
NPD37 |
Approved |
0.7727 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7704 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7701 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7644 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7637 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7629 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7629 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7612 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7576 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7576 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7574 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7565 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7565 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7563 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7529 |
Intermediate Similarity |
NPD5401 |
Approved |
0.75 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7458 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7437 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7435 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7398 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD943 |
Approved |
0.7371 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7341 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.733 |
Intermediate Similarity |
NPD2533 |
Approved |
0.733 |
Intermediate Similarity |
NPD2534 |
Approved |
0.733 |
Intermediate Similarity |
NPD2532 |
Approved |
0.733 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7323 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7322 |
Intermediate Similarity |
NPD919 |
Approved |
0.7299 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7263 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7263 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7254 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7225 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7186 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD920 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7135 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7122 |
Intermediate Similarity |
NPD7585 |
Approved |
0.712 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7069 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7035 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7029 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7016 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7930 |
Approved |
0.6994 |
Remote Similarity |
NPD6651 |
Approved |
0.6977 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD5408 |
Approved |
0.6971 |
Remote Similarity |
NPD5406 |
Approved |
0.6971 |
Remote Similarity |
NPD5404 |
Approved |
0.6971 |
Remote Similarity |
NPD6099 |
Approved |
0.6971 |
Remote Similarity |
NPD6100 |
Approved |
0.6971 |
Remote Similarity |
NPD5405 |
Approved |
0.6959 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6949 |
Remote Similarity |
NPD1243 |
Approved |
0.6936 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6936 |
Remote Similarity |
NPD447 |
Suspended |
0.6932 |
Remote Similarity |
NPD2344 |
Approved |
0.6931 |
Remote Similarity |
NPD5710 |
Approved |
0.6931 |
Remote Similarity |
NPD5711 |
Approved |
0.6923 |
Remote Similarity |
NPD2798 |
Approved |
0.691 |
Remote Similarity |
NPD8166 |
Discontinued |
0.691 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6888 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6834 |
Remote Similarity |
NPD4287 |
Approved |
0.6832 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6826 |
Remote Similarity |
NPD1091 |
Approved |
0.6826 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6816 |
Remote Similarity |
NPD7003 |
Approved |
0.6814 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6813 |
Remote Similarity |
NPD6273 |
Approved |
0.6788
|
Remote Similarity |
NPD7177 |
Discontinued |